Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $47.34 million. The enterprise value is $11.12 million.
| Market Cap | 47.34M |
| Enterprise Value | 11.12M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MREO has 159.62 million shares outstanding. The number of shares has increased by 5.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 159.62M |
| Shares Change (YoY) | +5.37% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 16.68% |
| Float | 117.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 94.69 |
| Forward PS | 5.04 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.48
| Current Ratio | 6.48 |
| Quick Ratio | 6.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -378.01 |
Financial Efficiency
Return on equity (ROE) is -75.87% and return on invested capital (ROIC) is -47.31%.
| Return on Equity (ROE) | -75.87% |
| Return on Assets (ROA) | -41.21% |
| Return on Invested Capital (ROIC) | -47.31% |
| Return on Capital Employed (ROCE) | -104.28% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | $12,821 |
| Profits Per Employee | -$915,641 |
| Employee Count | 39 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.37% in the last 52 weeks. The beta is 0.28, so MREO's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -89.37% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 46.82 |
| Average Volume (20 Days) | 2,892,873 |
Short Selling Information
The latest short interest is 8.16 million, so 6.29% of the outstanding shares have been sold short.
| Short Interest | 8.16M |
| Short Previous Month | 5.68M |
| Short % of Shares Out | 6.29% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, MREO had revenue of $500,000 and -$35.71 million in losses. Loss per share was -$0.22.
| Revenue | 500,000 |
| Gross Profit | 367,000 |
| Operating Income | -35.91M |
| Pretax Income | -35.71M |
| Net Income | -35.71M |
| EBITDA | -35.26M |
| EBIT | -35.91M |
| Loss Per Share | -$0.22 |
Balance Sheet
The company has $36.22 million in cash and n/a in debt, with a net cash position of $36.22 million or $0.23 per share.
| Cash & Cash Equivalents | 36.22M |
| Total Debt | n/a |
| Net Cash | 36.22M |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | 34.05M |
| Book Value Per Share | 0.21 |
| Working Capital | 33.86M |
Cash Flow
| Operating Cash Flow | -26.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 649,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -26.95M |
| FCF Per Share | -$0.17 |
Margins
| Gross Margin | 73.40% |
| Operating Margin | -7,182.20% |
| Pretax Margin | -7,142.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.37% |
| Shareholder Yield | -5.37% |
| Earnings Yield | -75.43% |
| FCF Yield | -56.93% |
Analyst Forecast
The average price target for MREO is $1.70, which is 473.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.70 |
| Price Target Difference | 473.16% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 331.51% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MREO has an Altman Z-Score of 4.69 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.69 |
| Piotroski F-Score | 1 |